Evidence map›Paper›PMID 42185340›Full record

ArticleNPJ Parkinson's disease2026

Machine learning-based optimization of dual subthalamic nucleus and substantia nigra targeting in deep brain stimulation.

Dallas Leavitt, Farzin Negahbani, Alireza Gharabaghi

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dallas LeavittInstitute for Neuromodulation and Neurotechnology (INN), University Hospital and University of Tübingen, Tübingen, Germany.
Farzin NegahbaniInstitute for Neuromodulation and Neurotechnology (INN), University Hospital and University of Tübingen, Tübingen, Germany.
Alireza GharabaghiInstitute for Neuromodulation and Neurotechnology (INN), University Hospital and University of Tübingen, Tübingen, Germany. alireza.gharabaghi@uni-tuebingen.de.

Funding

European Union's Joint Program for Neurodegenerative Disease Research 01ED2309
6 · The paper itself

Abstract

Advances in deep brain stimulation lead technology have created new opportunities for multi-site network modulation, including applications for freezing of gait, but systematic strategies for trajectory planning are lacking. We evaluated trajectories targeting the subthalamic nucleus (STN) and the simultaneous engament of the substantia nigra (SN), specifically its pars reticulata (SNr), which is considered as a potential target in Parkinson's disease. By analyzing 612 electrode trajectories implanted with standard protocols, we found that 61% of trajectories engaged the SNr; simulating larger array spans or deeper implantation depth increased SNr engagement to 76%. We then trained Gaussian Process Classifiers to predict successful SNr engagement. Targeting a point ≥1.5 mm lateral to the medial STN border along Bejjani's line, with an AC-PC angle ≥55° was associated with a ≥ 95% probability of yielding an SNr trajectory. This framework demonstrates that machine learning-assisted data analysis can generate planning principles for precise dual-site stimulation approaches.

Identifiers

PMID42185340
PMCPMC13201750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.